ProShares Ultra Health Care
21 hedge funds and large institutions have $8.07M invested in ProShares Ultra Health Care in 2017 Q4 according to their latest regulatory filings, with 4 funds opening new positions, 3 increasing their positions, 6 reducing their positions, and 2 closing their positions.
526% more call options, than puts
Call options by funds: $2.87M | Put options by funds: $459K
100% more first-time investments, than exits
New positions opened: 4 | Existing positions closed: 2
11% more funds holding
Funds holding: 19 → 21 (+2)
3.96% less ownership
Funds ownership: 33.22% → 29.26% (-4%)
15% less capital invested
Capital invested by funds: $9.44M → $8.07M (-$1.37M)
50% less repeat investments, than reductions
Existing positions increased: 3 | Existing positions reduced: 6
Top Buyers
| Rank | Fund | Capital Flow |
|---|---|---|
| 1 |
ACM
Avalon Capital Management
Port Of Redwood City,
California
|
+$892K |
| 2 |
Susquehanna International Group
Bala Cynwyd,
Pennsylvania
|
+$650K |
| 3 |
CIBC Private Wealth Group
Atlanta,
Georgia
|
+$48.7K |
| 4 |
CG
Cutler Group
San Francisco,
California
|
+$34.8K |
| 5 |
Citigroup
New York
|
+$33K |
Top Sellers
| Rank | Fund | Capital Flow |
|---|---|---|
| 1 |
GWM
Geneos Wealth Management
Englewood,
Colorado
|
-$1.98M |
| 2 |
AG
Advisor Group
Phoenix,
Arizona
|
-$987K |
| 3 |
Jane Street
New York
|
-$243K |
| 4 |
Morgan Stanley
New York
|
-$33K |
| 5 |
Envestnet Asset Management
Chicago,
Illinois
|
-$29K |
RXL Hedge Fund Activity: Q4 2017 in Review
21 of the 4,419 institutional investors tracked by Wall St. Rank reported a position in ProShares Ultra Health Care (RXL) for Q4 2017, worth a combined $8.07M — down 15% from $9.44M a quarter earlier.
Buyers outnumbered sellers: 4 funds opened new RXL positions and 2 closed out — a net gain of 2 holders — while 3 added to existing stakes and 6 trimmed.
The largest buyer was Avalon Capital Management, opening a new position worth an estimated $892K. The largest seller was Geneos Wealth Management, exiting entirely with an estimated $1.98M sold.
- 21 institutional investors held ProShares Ultra Health Care (RXL) as of Q4 2017, up from 19 in Q3 2017.
- Funds reported $8.07M of ProShares Ultra Health Care stock for Q4 2017, down 15% quarter-over-quarter.
- 4 funds opened new ProShares Ultra Health Care positions in Q4 2017 and 2 closed out, a net change of +2 holders.
- The largest ProShares Ultra Health Care buyer in Q4 2017 was Avalon Capital Management, an estimated $892K added.
- The largest ProShares Ultra Health Care seller in Q4 2017 was Geneos Wealth Management, an estimated $1.98M sold.
Based on aggregated 13F filings for Q4 2017.